PURPOSE: To describe the pathological features and assess the diagnostic information of different MR sequences in @entity1 with primary, secondary, and mixed (phlebo-, lipophlebo-, or lipolymphedema) forms of @entity4269 of the lower leg. MATERIAL AND METHODS: In 26 @entity1 with clinical diagnoses of primary (n=10), pure secondary (n=4), mixed (n=9) and combined secondary and mixed forms of @entity4269 (n=3), MR imaging was performed with coronal and axial T1 SE, T2 TSE, fat-suppressed (SPIR) T2 sequences and axial T1 SE after i.v. injection of @entity7241 . RESULTS: In 24 @entity1 there was a honeycomb pattern in the subcutis with a signal intensity corresponding to fluid (n=11), @entity82 (n=3), or both (n=10). Five @entity1 with @entity4269 showed @entity409 . Dermal @entity4 was noted in 23 @entity1 . Fat or @entity4 components in the muscles were mostly seen in @entity1 with phlebolymphedema. The honeycomb pattern was best seen on coronal T1 images, and fluid accumulations on axial SPIR-T2 images. @entity82 was only assessible from the T2 TSE sequence. @entity7241 did not improve the diagnostic information. CONCLUSION: For evaluation of @entity4269 and its mixed forms, an axial T2-weighted SPIR sequence in conjunction with a coronal T1 SE sequence are sufficient.

MR imaging of primary, secondary, and mixed forms of XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity82 :: ('MESH:D005355', 'Disease') :: ['fibrosis', 'Fibrosis'] @entity4 :: ('MESH:D004487', 'Disease') :: ['edema'] @entity4269 :: ('MESH:D008209', 'Disease') :: ['lymphedema', 'primary lymphedema'] @entity409 :: ('MESH:D008107', 'Disease') :: ['subfascial fluid accumulation'] @entity7241 :: ('MESH:D019786', 'Chemical') :: ['Gd-DTPA']
@entity4269 :: (MESH:D008209,Disease) :: ['lymphedema']
